Marksans Pharma informs about transcript of earnings call

25 Nov 2024 Evaluate
Marksans Pharma has informed that it enclosed earnings call transcript for Q2FY25 financial performance and strategy update.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

178.25 -0.65 (-0.36%)
29-Dec-2025 14:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1713.20
Dr. Reddys Lab 1267.55
Cipla 1494.85
Zydus Lifesciences 906.00
Lupin 2086.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×